Skip to search boxSkip to navigationSkip to main content

Association of cigarette smoking with interval to biochemical recurrence after radical prostatectomy: Results from the SEARCH database

  • Daniel M. Moreira
    ,
  • Jodi A. Antonelli
    ,
  • Joseph C. Presti
    ,
  • William J. Aronson
    ,
  • ,
  • Christopher J. Kane
  • Duke University
    ,
  • Durham Veterans Affairs Medical Center
    ,
  • Stanford University
    ,
  • Department of Veterans Affairs
    ,
  • VA Medical Center
    ,
  • University of California at Los Angeles
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Objectives: To analyze the association between cigarette smoking and biochemical recurrence (BCR) after radical prostatectomy among men from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort. Methods: We performed a retrospective analysis of 1267 subjects from the SEARCH cohort treated from 1998 to 2008 with smoking status available from the preoperative notes. A comparison of the baseline patient and disease characteristics between the current smokers and nonsmokers (past and never smokers combined) was performed using the chi-square and rank sum tests. The univariate and multivariate associations between smoking status and BCR-free survival were analyzed using Kaplan-Meier plots, the log-rank test, and Cox proportional hazard models. Results: Of the 1267 patients, 408 (32%) were active smokers and 859 (68%) were nonsmokers at surgery. The current smokers were younger (P <.001), more likely to be black (P <.001), and had a lower body mass index (P <.001), a greater percentage of positive biopsy cores (P = .039), a greater preoperative prostate-specific antigen level (P = .003), more extracapsular extension (P = .003) and seminal vesicle invasion (P = .029), and lower prostate volumes (P = .002). On univariate analysis, smokers had a risk of BCR similar to that of nonsmokers (hazard ratio 1.19, P = .129). On multivariate analysis, smoking was associated with an increased risk of BCR when adjusted for body mass index only (hazard ratio 1.37, P = .008). However, after adjustment for multiple preoperative characteristics, the association was attenuated and no longer statistically significant (hazard ratio 1.12, P = .325). After additional adjustment for postoperative features, such as tumor grade and stage, smoking was unrelated to the risk of BCR (hazard ratio 0.91, P = .502). Conclusions: Among patients undergoing radical prostatectomy in the SEARCH cohort, cigarette smoking was associated with slightly more advanced disease but a similar risk of BCR.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1218-1223 (6 pages)

Journal (Volume, Issue Number)

Urology (Volume 76, Issue 5)

Publication milestones

  • Published - 11/2010

Publication status

Published - 11/2010

ISSN

0090-4295

Publication IDs

  • Scopus: 78149358198
  • PubMed: 20381838

Publication metrics

Metrics

SciVal
citations
24
Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1
Scopus
citations
SciVal
FWCI
1.44
SciVal
Author count
8
SciVal
Paper percentile
79

PlumX, opens in new tab

Captures
20
Citation count
27

Funding Details

This study was supported by the Department of Veterans Affairs, National Institute of Health grant R01CA100938 (to W. J. Aronson), National Institutes of Health Specialized Programs of Research Excellence grant P50 CA92131-01A1 (to W. J. Aronson), the Georgia Cancer Coalition (to M. K. Terris), Department of Defense Prostate Cancer Research Program (to S. J. Freedland), and the American Urological Association Foundation/Astellas Rising Star in Urology Award (to S. J. Freedland).
FundersFunding numbers
American Urological Association Foundation/Astellas Rising Star
-
US Army Department of Defense Prostate Cancer Research Program
-
NIH
P50 CA92131-01A1
NCI
R01CA100938
VA
-
GCC
-